#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infertility male Myelin oligodendrocyte glycoprotein antibody-associated disease Non-small cell lung cancer Bone marrow disorder Congenital leptin deficiency Oropharyngeal cancer recurrent Essential thrombocythaemia NTRK gene fusion overexpression Skin cancer Kidney transplant rejection Hepatic cirrhosis Gastrointestinal neuroendocrine tumour Piriformis syndrome Mucopolysaccharidosis II Pulmonary arterial hypertension More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Diagnostics MELAS syndrome – Treatment Congenital hypotransferrinaemia – Life with Disease Hepatic angiosarcoma – Diagnostics Primary biliary cholangitis – Diagnostics Friedreich’s ataxia – Life with Disease Primary hyperoxaluria – Life with Disease Osteosarcoma recurrent – Life with Disease Haemophilia B with anti factor IX – Treatment Methylmalonic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Palivizumab Pegvaliase Adg126 GS-4321 ALLO-QUADCAR01-T Io102 Hydrochloride Ozanimod ADX-038 Wt1 Mrna Dc Ammonium Chloride Erythromycin Lactobionate Maribavir Mdna11 Trandolapril Icosapent Ethyl Metformin Zopiclone Etifoxine Hydrochloride Alx148 Rgx-202 More therapies…

    Learn about Your Condition

    Rosai-Dorfman syndrome Deafness Pelizaeus-Merzbacher disease Leukocyte adhesion deficiency Arrhythmia Thrombectomy Aplastic anaemia Bronchostenosis Anal cancer stage II Procedural anxiety Open angle glaucoma Takayasu's arteritis Dry eye Glioblastoma Renal cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Icosapent Ethyl
    • Tiemonium Methylsulphate
    • Empagliflozin
    Austria Germany Poland

  • Study on Reducing Chronic Migraine Days with CGRP Antibodies and Botulinum Toxin A in Adults Aged 18-70

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Erenumab
    • Fremanezumab
    Norway

  • Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Belgium Bulgaria Denmark France Greece Hungary +3

  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Relacorilant
    • Bevacizumab
    • Paclitaxel Albumin-Bound
    Belgium France Germany Italy Poland Spain

  • Study on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Drugs:
    • ORX750
    France Italy Spain

  • Study on Faster Weaning from Ventilators in Critically Ill Patients Using Levosimendan and a Drug Combination

    Recruiting

    3 1 1
    Investigated Diseases:
    • Weaning failure
    Investigated Drugs:
    • Biotin
    • Folic Acid
    • Levosimendan
    The Netherlands
Previous Page
1 … 212 213 214 215 216 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!